Novel Functional Complexity of Polycystin-1 by GPS Cleavage In Vivo: Role in Polycystic Kidney Disease

REFERENCES

• Gabow PA. 1993. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 329:332–342. http://dx.doi.org/10.1056/NEJM199307293290508.
   PubMed Web of Science ®Google Scholar
• Ahrabi AK, Jouret F, Marbaix E, Delporte C, Horie S, Mulroy S, Boulter C, Sandford R, Devuyst O. 2010. Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion. Nephrol. Dial. Transplant. 25:1067–1078. http://dx.doi.org/10.1093/ndt/gfp611.
   PubMedGoogle Scholar
• Lu W, Shen X, Pavlova A, Lakkis M, Ward CJ, Pritchard L, Harris PC, Genest DR, Perez-Atayde AR, Zhou J. 2001. Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum. Mol. Genet. 10:2385–2396. http://dx.doi.org/10.1093/hmg/10.21.2385.
   PubMed Web of Science ®Google Scholar
• Piontek KB, Huso DL, Grinberg A, Liu L, Bedja D, Zhao H, Gabrielson K, Qian F, Mei C, Westphal H, Germino GG. 2004. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J. Am. Soc. Nephrol. 15:3035–3043. http://dx.doi.org/10.1097/01.ASN.0000144204.01352.86.
   PubMedGoogle Scholar
• Piontek K, Menezes LF, Garcia-Gonzalez MA, Huso DL, Germino GG. 2007. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat. Med. 13:1490–1495. http://dx.doi.org/10.1038/nm1675.
   PubMed Web of Science ®Google Scholar
• Kim K, Drummond I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout MA. 2000. Polycystin 1 is required for the structural integrity of blood vessels. Proc. Natl. Acad. Sci. U. S. A. 97:1731–1736. http://dx.doi.org/10.1073/pnas.040550097.
   PubMed Web of Science ®Google Scholar
• Chauvet V, Qian F, Boute N, Cai Y, Phakdeekitacharoen B, Onuchic LF, Attie-Bitach T, Guicharnaud L, Devuyst O, Germino GG, Gubler MC. 2002. Expression of PKD1 and PKD2 transcripts and proteins in human embryo and during normal kidney development. Am. J. Pathol. 160:973–983. http://dx.doi.org/10.1016/S0002-9440(10)64919-X.
   PubMedGoogle Scholar
• Foggensteiner L, Bevan AP, Thomas R, Coleman N, Boulter C, Bradley J, Ibraghimov-Beskrovnaya O, Klinger K, Sandford R. 2000. Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene. J. Am. Soc. Nephrol. 11:814–827.
   PubMed Web of Science ®Google Scholar
• Guillaume R, D'Agati V, Daoust M, Trudel M. 1999. Murine Pkd1 is a developmentally regulated gene from morula to adulthood: role in tissue condensation and patterning. Dev. Dyn. 214:337–348. http://dx.doi.org/10.1002/(SICI)1097-0177(199904)214:4<337::AID-AJA6>3.0.CO;2-O.
   PubMedGoogle Scholar
• Guillaume R, Trudel M. 2000. Distinct and common developmental expression patterns of the murine Pkd2 and Pkd1 genes. Mech. Dev. 93:179–183. http://dx.doi.org/10.1016/S0925-4773(00)00257-4.
   PubMedGoogle Scholar
• Van Adelsberg J, Chamberlain S, D'Agati V. 1997. Polycystin expression is temporally and spatially regulated during renal development. Am. J. Physiol. 272:F602–F609.
   PubMedGoogle Scholar
• Geng L, Segal Y, Peissel B, Deng N, Pei Y, Carone F, Rennke HG, Glucksmann-Kuis AM, Schneider MC, Ericsson M, Reeders ST, Zhou J. 1996. Identification and localization of polycystin, the PKD1 gene product. J. Clin. Invest. 98:2674–2682. http://dx.doi.org/10.1172/JCI119090.
   PubMed Web of Science ®Google Scholar
• Palsson R, Sharma CP, Kim K, McLaughlin M, Brown D, Arnaout MA. 1996. Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1. Mol. Med. 2:702–711.
   PubMedGoogle Scholar
• Geng L, Segal Y, Pavlova A, Barros EJ, Lohning C, Lu W, Nigam SK, Frischauf AM, Reeders ST, Zhou J. 1997. Distribution and developmentally regulated expression of murine polycystin. Am. J. Physiol. 272:F451–F459.
   PubMed Web of Science ®Google Scholar
• Kleymenova E, Ibraghimov-Beskrovnaya O, Kugoh H, Everitt J, Xu H, Kiguchi K, Landes G, Harris P, Walker C. 2001. Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. Mol. Cell 7:823–832. http://dx.doi.org/10.1016/S1097-2765(01)00226-X.
   PubMed Web of Science ®Google Scholar
• Boletta A, Qian F, Onuchic LF, Bragonzi A, Cortese M, Deen PM, Courtoy PJ, Soria MR, Devuyst O, Monaco L, Germino GG. 2001. Biochemical characterization of bona fide polycystin-1 in vitro and in vivo. Am. J. Kidney Dis. 38:1421–1429. http://dx.doi.org/10.1053/ajkd.2001.29282.
   PubMedGoogle Scholar
• Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J. 2003. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33:129–137. http://dx.doi.org/10.1038/ng1076.
   PubMed Web of Science ®Google Scholar
• Yoder BK, Hou X, Guay-Woodford LM. 2002. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J. Am. Soc. Nephrol. 13:2508–2516. http://dx.doi.org/10.1097/01.ASN.0000029587.47950.25.
   PubMed Web of Science ®Google Scholar
• Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC. 1995. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 10:151–160. http://dx.doi.org/10.1038/ng0695-151.
   PubMed Web of Science ®Google Scholar
• Ponting CP, Hofmann K, Bork P. 1999. A latrophilin/CL-1-like GPS domain in polycystin-1. Curr. Biol. 9:R585–R588. http://dx.doi.org/10.1016/S0960-9822(99)80379-0.
   PubMedGoogle Scholar
• Wei W, Hackmann K, Xu H, Germino G, Qian F. 2007. Characterization of cis-autoproteolysis of polycystin-1, the product of human polycystic kidney disease 1 gene. J. Biol. Chem. 282:21729–21737. http://dx.doi.org/10.1074/jbc.M703218200.
   PubMedGoogle Scholar
• Qian F, Boletta A, Bhunia AK, Xu H, Liu L, Ahrabi AK, Watnick TJ, Zhou F, Germino GG. 2002. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc. Natl. Acad. Sci. U. S. A. 99:16981–16986. http://dx.doi.org/10.1073/pnas.252484899.
   PubMed Web of Science ®Google Scholar
• Arac D, Boucard AA, Bolliger MF, Nguyen J, Soltis SM, Sudhof TC, Brunger AT. 2012. A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis. EMBO J. 31:1364–1378. http://dx.doi.org/10.1038/emboj.2012.26.
   PubMed Web of Science ®Google Scholar
• Garcia-Gonzalez MA, Jones JG, Allen SK, Palatucci CM, Batish SD, Seltzer WK, Lan Z, Allen E, Qian F, Lens XM, Pei Y, Germino GG, Watnick TJ. 2007. Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease. Mol. Genet. Metab. 92:160–167. http://dx.doi.org/10.1016/j.ymgme.2007.05.004.
   PubMed Web of Science ®Google Scholar
• Qian F. 2012. Polycystin-1, p 3728–3736. In Rawlings ND, Salvesen G (ed), The handbook of proteolytic enzymes, 3rd ed. Academic Press, San Diego, CA.
   Google Scholar
• Yu S, Hackmann K, Gao J, He X, Piontek K, Garcia-Gonzalez MA, Menezes LF, Xu H, Germino GG, Zuo J, Qian F. 2007. Essential role of cleavage of polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure. Proc. Natl. Acad. Sci. U. S. A. 104:18688–18693. http://dx.doi.org/10.1073/pnas.0708217104.
   PubMedGoogle Scholar
• Fredriksson R, Lagerstrom MC, Hoglund PJ, Schioth HB. 2002. Novel human G protein-coupled receptors with long N-terminals containing GPS domains and Ser/Thr-rich regions. FEBS Lett. 531:407–414. http://dx.doi.org/10.1016/S0014-5793(02)03574-3.
   PubMed Web of Science ®Google Scholar
• Lin HH, Stacey M, Yona S, Chang GW. 2010. GPS proteolytic cleavage of adhesion-GPCRs. Adv. Exp. Med. Biol. 706:49–58. http://dx.doi.org/10.1007/978-1-4419-7913-1_4.
   PubMed Web of Science ®Google Scholar
• Sugita S, Ichtchenko K, Khvotchev M, Sudhof TC. 1998. α-Latrotoxin receptor CIRL/latrophilin 1 (CL1) defines an unusual family of ubiquitous G-protein-linked receptors. G-protein coupling not required for triggering exocytosis. J. Biol. Chem. 273:32715–32724.
   PubMed Web of Science ®Google Scholar
• Abe J, Fukuzawa T, Hirose S. 2002. Cleavage of Ig-Hepta at a “SEA” module and at a conserved G protein-coupled receptor proteolytic site. J. Biol. Chem. 277:23391–23398. http://dx.doi.org/10.1074/jbc.M110877200.
   PubMedGoogle Scholar
• Gray JX, Haino M, Roth MJ, Maguire JE, Jensen PN, Yarme A, Stetler-Stevenson MA, Siebenlist U, Kelly K. 1996. CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J. Immunol. 157:5438–5447.
   PubMed Web of Science ®Google Scholar
• Krasnoperov VG, Bittner MA, Beavis R, Kuang Y, Salnikow KV, Chepurny OG, Little AR, Plotnikov AN, Wu D, Holz RW, Petrenko AG. 1997. alpha-Latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor. Neuron 18:925–937. http://dx.doi.org/10.1016/S0896-6273(00)80332-3.
   PubMed Web of Science ®Google Scholar
• Lin HH, Chang GW, Davies JQ, Stacey M, Harris J, Gordon S. 2004. Autocatalytic cleavage of the EMR2 receptor occurs at a conserved G protein-coupled receptor proteolytic site motif. J. Biol. Chem. 279:31823–31832. http://dx.doi.org/10.1074/jbc.M402974200.
   PubMedGoogle Scholar
• Hsiao CC, Chen HY, Chang GW, Lin HH. 2011. GPS autoproteolysis is required for CD97 to up-regulate the expression of N-cadherin that promotes homotypic cell-cell aggregation. FEBS Lett. 585:313–318. http://dx.doi.org/10.1016/j.febslet.2010.12.005.
   PubMedGoogle Scholar
• Paavola KJ, Stephenson JR, Ritter SL, Alter SP, Hall RA. 2011. The N terminus of the adhesion G protein-coupled receptor GPR56 controls receptor signaling activity. J. Biol. Chem. 286:28914–28921. http://dx.doi.org/10.1074/jbc.M111.247973.
   PubMed Web of Science ®Google Scholar
• Promel S, Frickenhaus M, Hughes S, Mestek L, Staunton D, Woollard A, Vakonakis I, Schoneberg T, Schnabel R, Russ AP, Langenhan T. 2012. The GPS motif is a molecular switch for bimodal activities of adhesion class G protein-coupled receptors. Cell Rep. 2:321–331. http://dx.doi.org/10.1016/j.celrep.2012.06.015.
   PubMedGoogle Scholar
• Ward Y, Lake R, Yin JJ, Heger CD, Raffeld M, Goldsmith PK, Merino M, Kelly K. 2011. LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells. Cancer Res. 71:7301–7311. http://dx.doi.org/10.1158/0008-5472.CAN-11-2381.
   PubMed Web of Science ®Google Scholar
• Paavola KJ, Hall RA. 2012. Adhesion G protein-coupled receptors: signaling, pharmacology, and mechanisms of activation. Mol. Pharmacol. 82:777–783. http://dx.doi.org/10.1124/mol.112.080309.
   PubMed Web of Science ®Google Scholar
• Promel S, Langenhan T, Arac D. 2013. Matching structure with function: the GAIN domain of Adhesion-GPCR and PKD1-like proteins. Trends Pharmacol. Sci. 34:470–478. http://dx.doi.org/10.1016/j.tips.2013.06.002.
   PubMed Web of Science ®Google Scholar
• Kaur B, Brat DJ, Devi NS, Van Meir EG. 2005. Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor. Oncogene 24:3632–3642. http://dx.doi.org/10.1038/sj.onc.1208317.
   PubMed Web of Science ®Google Scholar
• Kaur B, Cork SM, Sandberg EM, Devi NS, Zhang Z, Klenotic PA, Febbraio M, Shim H, Mao H, Tucker-Burden C, Silverstein RL, Brat DJ, Olson JJ, Van Meir EG. 2009. Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism. Cancer Res. 69:1212–1220. http://dx.doi.org/10.1158/0008-5472.CAN-08-1166.
   PubMed Web of Science ®Google Scholar
• Herron BJ, Lu W, Rao C, Liu S, Peters H, Bronson RT, Justice MJ, McDonald JD, Beier DR. 2002. Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis. Nat. Genet. 30:185–189. http://dx.doi.org/10.1038/ng812.
   PubMedGoogle Scholar
• Kurbegovic A, Cote O, Couillard M, Ward CJ, Harris PC, Trudel M. 2010. Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes. Hum. Mol. Genet. 19:1174–1189. http://dx.doi.org/10.1093/hmg/ddp588.
   PubMed Web of Science ®Google Scholar
• Kurbegovic A, Trudel M. 2013. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain. Hum. Mol. Genet. 22:2361–2375. http://dx.doi.org/10.1093/hmg/ddt081.
   PubMedGoogle Scholar
• Wodarczyk C, Rowe I, Chiaravalli M, Pema M, Qian F, Boletta A. 2009. A novel mouse model reveals that polycystin-1 deficiency in ependyma and choroid plexus results in dysfunctional cilia and hydrocephalus. PLoS One 4:e7137. http://dx.doi.org/10.1371/journal.pone.0007137.
   PubMed Web of Science ®Google Scholar
• Thivierge C, Kurbegovic A, Couillard M, Guillaume R, Cote O, Trudel M. 2006. Overexpression of PKD1 causes polycystic kidney disease. Mol. Cell. Biol. 26:1538–1548. http://dx.doi.org/10.1128/MCB.26.4.1538-1548.2006.
   PubMed Web of Science ®Google Scholar
• Couillard M, Trudel M. 2009. C-myc as a modulator of renal stem/progenitor cell population. Dev. Dyn. 238:405–414. http://dx.doi.org/10.1002/dvdy.21841.
   PubMedGoogle Scholar
• Ong AC, Harris PC, Davies DR, Pritchard L, Rossetti S, Biddolph S, Vaux DJ, Migone N, Ward CJ. 1999. Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue. Kidney Int. 56:1324–1333. http://dx.doi.org/10.1046/j.1523-1755.1999.00659.x.
   PubMedGoogle Scholar
• Freeze HH. 2001. Use of glycosidases to study protein trafficking. Curr. Protoc. Cell Biol. Chapter 15:Unit 15.2. http://dx.doi.org/10.1002/0471143030.cb1502s03.
   Google Scholar
• Kornfeld R, Kornfeld S. 1985. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54:631–664. http://dx.doi.org/10.1146/annurev.bi.54.070185.003215.
   PubMed Web of Science ®Google Scholar
• Stanley P. 2011. Golgi glycosylation. Cold Spring Harb. Perspect. Biol. 3:a005199. http://dx.doi.org/10.1101/cshperspect.a005199.
   PubMedGoogle Scholar
• Chapin HC, Rajendran V, Caplan MJ. 2010. Polycystin-1 surface localization is stimulated by polycystin-2 and cleavage at the G protein-coupled receptor proteolytic site. Mol. Biol. Cell 21:4338–4348. http://dx.doi.org/10.1091/mbc.E10-05-0407.
   PubMedGoogle Scholar
• Krasnoperov V, Lu Y, Buryanovsky L, Neubert TA, Ichtchenko K, Petrenko AG. 2002. Post-translational proteolytic processing of the calcium-independent receptor of alpha-latrotoxin (CIRL), a natural chimera of the cell adhesion protein and the G protein-coupled receptor. Role of the G protein-coupled receptor proteolysis site (GPS) motif. J. Biol. Chem. 277:46518–46526. http://dx.doi.org/10.1074/jbc.M206415200.
   PubMed Web of Science ®Google Scholar
• Magenheimer BS, St John PL, Isom KS, Abrahamson DR, De Lisle RC, Wallace DP, Maser RL, Grantham JJ, Calvet JP. 2006. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na+, K+, 2Cl− Co-transporter-dependent cystic dilation. J. Am. Soc. Nephrol. 17:3424–3437. http://dx.doi.org/10.1681/ASN.2006030295.
   PubMedGoogle Scholar
• Xu H, Shen J, Walker CL, Kleymenova E. 2001. Tissue-specific expression and splicing of the rat polycystic kidney disease 1 gene. DNA Seq. 12:361–366.
   PubMed Web of Science ®Google Scholar
• Butscheid Y, Chubanov V, Steger K, Meyer D, Dietrich A, Gudermann T. 2006. Polycystic kidney disease and receptor for egg jelly is a plasma membrane protein of mouse sperm head. Mol. Reprod. Dev. 73:350–360. http://dx.doi.org/10.1002/mrd.20410.
   PubMedGoogle Scholar
• Jin Z, Tietjen I, Bu L, Liu-Yesucevitz L, Gaur SK, Walsh CA, Piao X. 2007. Disease-associated mutations affect GPR56 protein trafficking and cell surface expression. Hum. Mol. Genet. 16:1972–1985. http://dx.doi.org/10.1093/hmg/ddm144.
   PubMed Web of Science ®Google Scholar
• Kim H, Jeong W, Ahn K, Ahn C, Kang S. 2004. Siah-1 interacts with the intracellular region of polycystin-1 and affects its stability via the ubiquitin-proteasome pathway. J. Am. Soc. Nephrol. 15:2042–2049. http://dx.doi.org/10.1097/01.ASN.0000133490.00348.59.
   PubMedGoogle Scholar
• Low SH, Vasanth S, Larson CH, Mukherjee S, Sharma N, Kinter MT, Kane ME, Obara T, Weimbs T. 2006. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev. Cell 10:57–69. http://dx.doi.org/10.1016/j.devcel.2005.12.005.
   PubMed Web of Science ®Google Scholar
• Tsiokas L, Kim E, Arnould T, Sukhatme VP, Walz G. 1997. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc. Natl. Acad. Sci. U. S. A. 94:6965–6970. http://dx.doi.org/10.1073/pnas.94.13.6965.
   PubMed Web of Science ®Google Scholar
• Chauvet V, Tian X, Husson H, Grimm DH, Wang T, Hiesberger T, Igarashi P, Bennett AM, Ibraghimov-Beskrovnaya O, Somlo S, Caplan MJ. 2004. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J. Clin. Invest. 114:1433–1443. http://dx.doi.org/10.1172/JCI21753.
   PubMed Web of Science ®Google Scholar
• Woodward OM, Li Y, Yu S, Greenwell P, Wodarczyk C, Boletta A, Guggino WB, Qian F. 2010. Identification of a polycystin-1 cleavage product, P100, that regulates store operated Ca entry through interactions with STIM1. PLoS One 5:e12305. http://dx.doi.org/10.1371/journal.pone.0012305.
   PubMed Web of Science ®Google Scholar
• Porter JA, Young KE, Beachy PA. 1996. Cholesterol modification of hedgehog signaling proteins in animal development. Science 274:255–259. http://dx.doi.org/10.1126/science.274.5285.255.
   PubMed Web of Science ®Google Scholar
• Volynski KE, Silva JP, Lelianova VG, Atiqur Rahman M, Hopkins C, Ushkaryov YA. 2004. Latrophilin fragments behave as independent proteins that associate and signal on binding of LTX(N4C). EMBO J. 23:4423–4433. http://dx.doi.org/10.1038/sj.emboj.7600443.
   PubMed Web of Science ®Google Scholar
• Cornec-Le Gall E, Audrezet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Ferec C, Le Meur Y. 2013. Type of PKD1 Mutation Influences Renal Outcome in ADPKD. J. Am. Soc. Nephrol. 24:1006–1013. http://dx.doi.org/10.1681/ASN.2012070650.
   PubMed Web of Science ®Google Scholar